Clinical Next-Generation Sequencing (NGS) Data Analysis Market Trends Report 2025 – For Business Development and Strategy Teams
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Forecast for the Clinical Next-Generation Sequencing (NGS) Data Analysis Market Growth in 2025?
In recent times, there has been remarkable growth in the clinical next-generation sequencing (NGS) data analysis market. The market, which is valued at $3.43 billion in 2024, is projected to expand to $4.15 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 20.8%. The significant growth during the historic period is credited to progress in genomics research, falling costs of sequencing, rising demand for tailor-made medicine, an wider use in clinical diagnostics, and a higher occurrence of genetic ailments.
What Is the Forecast for the Clinical Next-Generation Sequencing (NGS) Data Analysis Market Size Through 2029?
The market size of clinical next-generation sequencing (NGS) data analysis is predicted to experience a rapid surge in upcoming years, with an estimation to reach around $8.73 billion in 2029, at a compound annual growth rate (CAGR) of 20.5%. Factors contributing to the growth forecast include increasing adoption of liquid biopsy techniques, the application of artificial intelligence in data analysis, the spread of precision medicine initiatives, the introduction of new sequencing technologies, and an increased emphasis on population genomics initiatives. The forecasted period is also marked with the growing presence of companion diagnostics, rising prominence of decentralized testing models, a surge in the use of cloud-based solutions, the widening application of NGS in non-invasive prenatal testing, and standardized protocols for data interpretation.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14877&type=smp
What are the Key Market Players in Clinical Next-Generation Sequencing (NGS) Data Analysis Market and How They’re Evolving?
Major companies operating in the clinical next-generation sequencing (NGS) data analysis market are Roche Diagnostics, Thermo Fisher Scientific Inc., Eurofins Scientific, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen, BGI Group, 10x Genomics, Genomic Health, Oxford Nanopore Technologies PLC., Pacific Biosciences of California Inc., Sophia Genetics, Genewiz, Partek Inc., DNAnexus, BioNano Genomics, PierianDx, GENAPSYS, Nugen Technologies, DNAStar Inc., Swift Biosciences, Basepair, BioDatomics, Congenica Ltd., Theragen Etex Inc., Golden Helix Inc.
What Are the Primary Growth Drivers in the Clinical Next-Generation Sequencing (NGS) Data Analysis Market?
The surge in the need for personalized medicines is predicted to drive the growth of the clinical next-generation sequencing data analysis market in the future. Personalized medicine involves a medical strategy that considers the unique genetic, environmental and lifestyle factors of each individual. This burgeoning desire for personalized treatments is due to genomic technologies, growing disease complexity, improved therapeutic results, and escalating healthcare expenses. The role of Next-generation sequencing (NGS) data analysis in personalized medicine is vital as it facilitates the quick and precise sequencing of multiple genes simultaneously, providing a profound understanding of a person’s genetic constitution. For example, in October 2022, as per publications by STAT, a healthcare-focused news agency based in the US, there were over 75,000 genetic testing products and 300 tailored medicines. Additionally, in 2023, the Personalized Medicine Coalition, a representative organization based in the U.S, reported that the FDA approved personalized medications for 34% of new drugs, and in the previous eight years, they had been sanctioned for a minimum of 25% of new pharmaceuticals. Consequently, the burgeoning need for customized medications is fueling the expansion of the clinical next-generation sequencing data analysis market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=14877&type=smp
What Are the Leading Segments in the Global Clinical Next-Generation Sequencing (NGS) Data Analysis Industry?
The clinical next-generation sequencing (NGS) data analysis market covered in this report is segmented –
1) By Solution And Services: NGS Data Analysis Tools, NGS Data Analysis And Sequencing Services, NGS Storage, Management And Cloud Computing Platform, Platforms
2) By Technology: Sequencing By Synthesis (SBS), Nanopore Sequencing, Single-Molecule Real-Time (SMRT) Sequencing, Other Technologies
3) By Application: Diagnostics, Drug Discovery And Designing, Medical Research, Other Applications
4) By End User: Hospitals And Clinics, Academic Institutes And Research Centers, Biotechnology Companies, Life Science Technology Vendors, Other End Users
Subsegments:
1) By NGS Data Analysis Tools: Software Platforms, Data Interpretation Tools, Bioinformatics Tools, Data Analytics Solutions
2) By NGS Data Analysis And Sequencing Services: Sequencing Services, Data Analysis Services, Consultation Services, Research And Diagnostic Services
3) By NGS Storage, Management, And Cloud Computing Platform: Data Storage Solutions, Data Management Platforms, Cloud-Based Platforms, Cloud Storage Services
4) By Platforms: Sequencing Platforms, NGS Instrumentation Platforms, Integrated NGS Platforms
What Are the Key Market Trends in the Clinical Next-Generation Sequencing (NGS) Data Analysis Industry?
Top-tier corporations active within the clinical next-generation sequencing (NGS) data analysis market are forging ahead with innovative premium solutions, like the NextSeq 2000 Sequencing System, in an effort to fulfil burgeoning requirements for precision in genomic analysis. This system is indicative of a complete suite of integrated hardware and software tools utilized to carry out DNA sequencing, a process which entails ascertaining the exact order of nucleotides in a DNA molecule. For example, in September 2022, Illumina Inc., an American biotech firm, introduced the NovaSeq X Series, an innovative new range of production-scale sequencers that deliver quicker, mightier, and more sustainable sequencing. The series constituted of the NovaSeq X and NovaSeq X Plus, are capable of producing over 20,000 whole genomes annually, which is 2.5 times the output of previous sequencers. These sequencers employ groundbreaking technology, incorporating a totally new sequencing by synthesis (SBS) chemistry (XLEAP-SBS) which is twice as quick and upto thrice more precise, coupled with higher-resolution optics, and ultra-dense flow cells that provide 2.5x higher throughput whilst reducing sequencing costs.
Access The Full Report Here:
What Is the Regional Outlook for the Clinical Next-Generation Sequencing (NGS) Data Analysis Market?
North America was the largest region in the clinical next-generation sequencing (NGS) data analysis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical next-generation sequencing (NGS) data analysis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14877
This Report Delivers Insight On:
1. How big is the clinical next-generation sequencing (ngs) data analysis market, and how is it changing globally?
2. Who are the major companies in the clinical next-generation sequencing (ngs) data analysis market, and how are they performing?
3. What are the key opportunities and risks in the clinical next-generation sequencing (ngs) data analysis market right now?
4. Which products or customer segments are growing the most in the clinical next-generation sequencing (ngs) data analysis market?
5. What factors are helping or slowing down the growth of the clinical next-generation sequencing (ngs) data analysis market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
